Lexaria Bioscience (LEXX) Share-based Compensation (2010 - 2026)
Lexaria Bioscience's Share-based Compensation was $92,944 in fiscal Q3 2026 (quarter ended May 31, 2026), down 80.2% from $470,136 a year earlier but up 24.1% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Lexaria Bioscience's Share-based Compensation was $365,458 through May 31, 2026, down 56.1% year-over-year; for FY2025 (ended Aug 31, 2025), it was $859,494, up 74.6% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 53.8% (FY2020 to FY2025).
- In earlier fiscal years, Share-based Compensation was $492,236 in FY2024 (+188.9%), $170,382 in FY2023 (-77.4%), $752,591 in FY2022 (+83.6%) and $410,007 in FY2021 (+310.0%).
- Quarterly Share-based Compensation has moved between $9,634 (fiscal Q4 2023) and $470,136 (fiscal Q3 2025) over five years.
- Compared with a year earlier, Share-based Compensation has declined for three straight quarters, with growth averaging 127.2% over the last seven quarters.
- The best year-over-year quarter for Share-based Compensation over five years was fiscal Q4 2024 (growth of 901.8%); the worst was fiscal Q4 2023 (a decline of 95.9%).
- Per Business Quant data, LEXX's Share-based Compensation in the three fiscal quarters before Q3 2026 was $74,895 (Q2 2026), $74,895 (Q1 2026) and $122,724 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Lexaria Bioscience | 3.39 Mn | -12.26 Mn | - | 92,944.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 92,944.00 |
| Feb 28, 2026 | 74,895.00 |
| Nov 30, 2025 | 74,895.00 |
| Aug 31, 2025 | 122,724.00 |
| May 31, 2025 | 470,136.00 |
| Feb 28, 2025 | 167,219.00 |
| Nov 30, 2024 | 99,415.00 |
| Aug 31, 2024 | 96,510.00 |
| May 31, 2024 | 341,773.00 |
| Nov 30, 2023 | 53,953.00 |
| Aug 31, 2023 | 9,634.00 |
| May 31, 2023 | 81,446.00 |
| Feb 28, 2023 | 10,526.00 |
| Nov 30, 2022 | 68,776.00 |
| Aug 31, 2022 | 232,873.00 |
| May 31, 2022 | 111,174.00 |
| Nov 30, 2021 | 408,544.00 |
| Aug 31, 2021 | 410,007.00 |
| Feb 28, 2021 | -3,825.00 |
| Nov 30, 2020 | 3,825.00 |
API Access
Lexaria Bioscience Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();